Dr. Dmitriy Sivtsov, MD

NPI: 1467553958
Total Payments
$15,717
2024 Payments
$1,733
Companies
28
Transactions
654
Medicare Patients
322
Medicare Billing
$117,514

Payment Breakdown by Category

Food & Beverage$15,588 (99.2%)
Education$128.75 (0.8%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $15,588 647 99.2%
Education $128.75 7 0.8%

Top Paying Companies

Company Total Records Latest Year
Otsuka America Pharmaceutical, Inc. $1,964 98 $0 (2024)
Sunovion Pharmaceuticals Inc. $1,634 52 $0 (2022)
ABBVIE INC. $1,343 54 $0 (2024)
Alkermes, Inc. $1,338 41 $0 (2024)
Allergan, Inc. $1,261 49 $0 (2020)
Lundbeck LLC $1,186 66 $0 (2024)
Janssen Pharmaceuticals, Inc $1,024 25 $0 (2024)
Bausch Health US, LLC $1,003 55 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $909.59 49 $0 (2024)
Axsome Therapeutics, Inc. $750.44 15 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,733 63 Otsuka America Pharmaceutical, Inc. ($286.07)
2023 $1,786 73 Axsome Therapeutics, Inc. ($496.70)
2022 $2,464 90 ABBVIE INC. ($407.15)
2021 $2,096 93 AbbVie Inc. ($463.04)
2020 $1,449 84 Otsuka America Pharmaceutical, Inc. ($214.08)
2019 $3,232 97 Sunovion Pharmaceuticals Inc. ($748.90)
2018 $1,735 91 Sunovion Pharmaceuticals Inc. ($359.39)
2017 $1,222 63 Allergan Inc. ($412.75)

All Payment Transactions

654 individual payment records from CMS Open Payments — Page 1 of 27

Date Company Product Nature Form Amount Type
12/18/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $28.96 General
Category: NEUROSCIENCE
12/16/2024 Bausch Health US, LLC APLENZIN (Drug) Food and Beverage In-kind items and services $24.88 General
Category: Neurology
12/12/2024 Takeda Pharmaceuticals U.S.A., Inc. TRINTELLIX (Drug) Food and Beverage In-kind items and services $29.32 General
Category: NEUROSCIENCE
12/05/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $25.26 General
Category: PSYCHIATRY
12/04/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $28.46 General
Category: PSYCHIATRY
11/25/2024 Bausch Health US, LLC APLENZIN (Drug) Food and Beverage In-kind items and services $22.76 General
Category: Neurology
11/14/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $102.31 General
Category: PSYCHIATRY
11/07/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $26.84 General
Category: PSYCHIATRY
10/29/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $27.72 General
Category: PSYCHIATRY
10/11/2024 Takeda Pharmaceuticals U.S.A., Inc. TRINTELLIX (Drug) Food and Beverage In-kind items and services $28.48 General
Category: NEUROSCIENCE
10/08/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $33.09 General
Category: NEUROSCIENCE
10/03/2024 Janssen Pharmaceuticals, Inc SPRAVATO (Drug) Food and Beverage In-kind items and services $27.95 General
Category: Neuroscience
10/02/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $27.75 General
Category: PSYCHIATRY
10/02/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $7.22 General
Category: PSYCHIATRY
09/25/2024 Takeda Pharmaceuticals U.S.A., Inc. TRINTELLIX (Drug) Education In-kind items and services $7.53 General
Category: NEUROSCIENCE
09/05/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $24.15 General
Category: PSYCHIATRY
08/30/2024 Takeda Pharmaceuticals U.S.A., Inc. TRINTELLIX (Drug) Education In-kind items and services $7.53 General
Category: NEUROSCIENCE
08/22/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $110.00 General
Category: NEUROSCIENCE
08/20/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $26.01 General
Category: NEUROSCIENCE
08/15/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $16.06 General
Category: PSYCHIATRY
08/08/2024 Vanda Pharmaceuticals Inc. FANAPT (Drug) Food and Beverage In-kind items and services $31.86 General
Category: SCHIZOPHRENIA
08/06/2024 Janssen Pharmaceuticals, Inc SPRAVATO (Drug) Food and Beverage In-kind items and services $31.87 General
Category: Neuroscience
08/05/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $6.92 General
Category: NEUROSCIENCE
08/01/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $27.50 General
Category: PSYCHIATRY
07/31/2024 Bausch Health US, LLC APLENZIN (Drug) Food and Beverage In-kind items and services $14.85 General
Category: Neurology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 2 40 149 $53,450 $17,565
2022 2 54 128 $34,725 $13,835
2021 2 76 208 $53,000 $22,146
2020 7 152 637 $334,300 $63,968
Total Patients
322
Total Services
1,122
Medicare Billing
$117,514
Procedure Codes
13

All Medicare Procedures & Services

13 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 20 95 $41,250 $13,737 33.3%
90836 Psychotherapy with evaluation and management visit, 45 minutes Office 2023 20 54 $12,200 $3,828 31.4%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 27 64 $21,175 $9,104 43.0%
90836 Psychotherapy with evaluation and management visit, 45 minutes Office 2022 27 64 $13,550 $4,731 34.9%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 38 104 $32,100 $14,332 44.6%
90836 Psychotherapy with evaluation and management visit, 45 minutes Office 2021 38 104 $20,900 $7,814 37.4%
90868 Transcranial magnetic stimulation treatment (stimulates nerve cells in brain to improve symptoms of depression), per session Office 2020 13 297 $207,900 $28,224 13.6%
99215 Established patient office or other outpatient, visit typically 40 minutes Office 2020 41 120 $35,150 $13,087 37.2%
90869 Transcranial magnetic stimulation treatment (stimulates nerve cells in brain to improve symptoms of depression) Office 2020 13 56 $54,600 $8,821 16.2%
90836 Psychotherapy, 45 minutes Office 2020 41 120 $24,050 $8,705 36.2%
99205 New patient office or other outpatient visit, typically 60 minutes Office 2020 16 16 $5,600 $2,307 41.2%
90838 Psychotherapy, 60 minutes Office 2020 16 16 $4,000 $1,609 40.2%
96130 Psychological testing evaluation by qualified health care professional, first 60 minutes Office 2020 12 12 $3,000 $1,216 40.5%

About Dr. Dmitriy Sivtsov, MD

Dr. Dmitriy Sivtsov, MD is a Psychiatry healthcare provider based in San Diego, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1467553958.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dmitriy Sivtsov, MD has received a total of $15,717 in payments from pharmaceutical and medical device companies, with $1,733 received in 2024. These payments were reported across 654 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($15,588).

As a Medicare-enrolled provider, Sivtsov has provided services to 322 Medicare beneficiaries, totaling 1,122 services with total Medicare billing of $117,514. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.

Practice Information

  • Specialty Psychiatry
  • Location San Diego, CA
  • Active Since 09/26/2006
  • Last Updated 03/13/2024
  • Taxonomy Code 2084P0800X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1467553958

Products in Payments

  • VRAYLAR (Drug) $2,462
  • REXULTI (Drug) $2,090
  • LATUDA (Drug) $1,634
  • SPRAVATO (Drug) $956.37
  • TRINTELLIX (Drug) $951.96
  • APLENZIN (Drug) $930.05
  • ARISTADA (Drug) $877.02
  • Auvelity (Drug) $750.44
  • CAPLYTA (Drug) $610.54
  • ABILIFY MAINTENA (Drug) $400.53
  • BELSOMRA (Drug) $301.91
  • AUSTEDO (Drug) $291.50
  • Dayvigo (Drug) $252.68
  • BRINTELLIX (Drug) $242.66
  • LYBALVI (Drug) $242.43
  • MYDAYIS (Drug) $231.07
  • INGREZZA (Drug) $210.51
  • ABILIFY MYCITE (Drug) $186.38
  • Trintellix (Drug) $184.94
  • QUVIVIQ (Drug) $179.59

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Psychiatry Doctors in San Diego